1. Fragment-based drug discovery: what really works. An interview with Sandy Farmer of Boehringer Ingelheim

   • Wendy A. Warr

   Warr's Piece 16 July 2011 Pages: 599 - 605

   

2. Fragment-based lead discovery: challenges and opportunities

   • Chaohong Sun
   • Andrew M. Petros
   • Philip J. Hajduk

   OriginalPaper 06 July 2011 Pages: 607 - 610

   

3. Design of a Fragment Library that maximally represents available chemical space

   • M. N. Schulz
   • J. Landström
   • R. E. Hubbard

   OriginalPaper 27 July 2011 Pages: 611 - 620

   

4. Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics

   • Wan F. Lau
   • Jane M. Withka
   • James E. Mills

   OriginalPaper 21 May 2011 Pages: 621 - 636

   

5. Visualisation and subsets of the chemical universe database GDB-13 for virtual screening

   • Lorenz C. Blum
   • Ruud van Deursen
   • Jean-Louis Reymond

   OriginalPaper 27 May 2011 Pages: 637 - 647

   

6. Visualisation of the chemical space of fragments, lead-like and drug-like molecules in PubChem

   • Ruud van Deursen
   • Lorenz C. Blum
   • Jean-Louis Reymond

   OriginalPaper 27 May 2011 Pages: 649 - 662

   

7. Assessing the lipophilicity of fragments and early hits

   • Paul N. Mortenson
   • Christopher W. Murray

   OriginalPaper 26 May 2011 Pages: 663 - 667

   

8. Biosensor-based small molecule fragment screening with biolayer interferometry

   • Charles A. Wartchow
   • Frank Podlaski
   • Kuo-Sen Huang

   OriginalPaper 10 June 2011 Pages: 669 - 676

   

9. A comparative study of fragment screening methods on the p38α kinase: new methods, new insights

   • Scott J. Pollack
   • Kim S. Beyer
   • Roland W. Bürli

   OriginalPaper Open access 06 July 2011 Pages: 677 - 687

   

10. Novel isoquinolone PDK1 inhibitors discovered through fragment-based lead discovery

    • M. Catherine Johnson
    • Qiyue Hu
    • Gordon Alton

    OriginalPaper 22 July 2011 Pages: 689 - 698